Singapore’s Clinical Trials Registry May Attract Wider Patient Pool
This article was originally published in PharmAsia News
Executive Summary
The launch of a clinical trials registry in Singapore is another step in the wealthy city-state’s efforts to serve as a treatment hub in Asia for cutting-edge therapies.